1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tumorigenesis research
1.3.3 EMT biomarkers development
1.3.4 Cancer stem cell research
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cell Diagnostics Market Perspective (2017-2028)
2.2 Circulating Tumor Cell Diagnostics Growth Trends by Region
2.2.1 Circulating Tumor Cell Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Circulating Tumor Cell Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Circulating Tumor Cell Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Circulating Tumor Cell Diagnostics Market Dynamics
2.3.1 Circulating Tumor Cell Diagnostics Industry Trends
2.3.2 Circulating Tumor Cell Diagnostics Market Drivers
2.3.3 Circulating Tumor Cell Diagnostics Market Challenges
2.3.4 Circulating Tumor Cell Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cell Diagnostics Players by Revenue
3.1.1 Global Top Circulating Tumor Cell Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Circulating Tumor Cell Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cell Diagnostics Revenue
3.4 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio
3.4.1 Global Circulating Tumor Cell Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell Diagnostics Revenue in 2021
3.5 Circulating Tumor Cell Diagnostics Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cell Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cell Diagnostics Breakdown Data by Type
4.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Type (2023-2028)
5 Circulating Tumor Cell Diagnostics Breakdown Data by Application
5.1 Global Circulating Tumor Cell Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Circulating Tumor Cell Diagnostics Market Size (2017-2028)
6.2 North America Circulating Tumor Cell Diagnostics Market Size by Type
6.2.1 North America Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Circulating Tumor Cell Diagnostics Market Share by Type (2017-2028)
6.3 North America Circulating Tumor Cell Diagnostics Market Size by Application
6.3.1 North America Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Circulating Tumor Cell Diagnostics Market Share by Application (2017-2028)
6.4 North America Circulating Tumor Cell Diagnostics Market Size by Country
6.4.1 North America Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Circulating Tumor Cell Diagnostics Market Size (2017-2028)
7.2 Europe Circulating Tumor Cell Diagnostics Market Size by Type
7.2.1 Europe Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Circulating Tumor Cell Diagnostics Market Share by Type (2017-2028)
7.3 Europe Circulating Tumor Cell Diagnostics Market Size by Application
7.3.1 Europe Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Circulating Tumor Cell Diagnostics Market Share by Application (2017-2028)
7.4 Europe Circulating Tumor Cell Diagnostics Market Size by Country
7.4.1 Europe Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Type
8.2.1 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Circulating Tumor Cell Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Application
8.3.1 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Circulating Tumor Cell Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Region
8.4.1 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cell Diagnostics Market Size (2017-2028)
9.2 Latin America Circulating Tumor Cell Diagnostics Market Size by Type
9.2.1 Latin America Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Circulating Tumor Cell Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Circulating Tumor Cell Diagnostics Market Size by Application
9.3.1 Latin America Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Circulating Tumor Cell Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Circulating Tumor Cell Diagnostics Market Size by Country
9.4.1 Latin America Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Type
10.2.1 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Circulating Tumor Cell Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Application
10.3.1 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Circulating Tumor Cell Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Country
10.4.1 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Janssen Diagnostics
11.1.1 Janssen Diagnostics Company Details
11.1.2 Janssen Diagnostics Business Overview
11.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Introduction
11.1.4 Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.1.5 Janssen Diagnostics Recent Developments
11.2 Advanced Cell Diagnostics
11.2.1 Advanced Cell Diagnostics Company Details
11.2.2 Advanced Cell Diagnostics Business Overview
11.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Introduction
11.2.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.2.5 Advanced Cell Diagnostics Recent Developments
11.3 Aviva Biosciences
11.3.1 Aviva Biosciences Company Details
11.3.2 Aviva Biosciences Business Overview
11.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Introduction
11.3.4 Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.3.5 Aviva Biosciences Recent Developments
11.4 Biocept Inc
11.4.1 Biocept Inc Company Details
11.4.2 Biocept Inc Business Overview
11.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Introduction
11.4.4 Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.4.5 Biocept Inc Recent Developments
11.5 Biofluidica Inc.
11.5.1 Biofluidica Inc. Company Details
11.5.2 Biofluidica Inc. Business Overview
11.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Introduction
11.5.4 Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.5.5 Biofluidica Inc. Recent Developments
11.6 CellTraffix Inc.
11.6.1 CellTraffix Inc. Company Details
11.6.2 CellTraffix Inc. Business Overview
11.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Introduction
11.6.4 CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.6.5 CellTraffix Inc. Recent Developments
11.7 Clearbridge BioMedics Pte Ltd
11.7.1 Clearbridge BioMedics Pte Ltd Company Details
11.7.2 Clearbridge BioMedics Pte Ltd Business Overview
11.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Introduction
11.7.4 Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.7.5 Clearbridge BioMedics Pte Ltd Recent Developments
11.8 Epic Sciences Inc.
11.8.1 Epic Sciences Inc. Company Details
11.8.2 Epic Sciences Inc. Business Overview
11.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Introduction
11.8.4 Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.8.5 Epic Sciences Inc. Recent Developments
11.9 Fluxion Biosciences Inc.
11.9.1 Fluxion Biosciences Inc. Company Details
11.9.2 Fluxion Biosciences Inc. Business Overview
11.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Introduction
11.9.4 Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.9.5 Fluxion Biosciences Inc. Recent Developments
11.10 ScreenCell
11.10.1 ScreenCell Company Details
11.10.2 ScreenCell Business Overview
11.10.3 ScreenCell Circulating Tumor Cell Diagnostics Introduction
11.10.4 ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.10.5 ScreenCell Recent Developments
11.11 Silicon Biosystems
11.11.1 Silicon Biosystems Company Details
11.11.2 Silicon Biosystems Business Overview
11.11.3 Silicon Biosystems Circulating Tumor Cell Diagnostics Introduction
11.11.4 Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.11.5 Silicon Biosystems Recent Developments
11.12 Sysmex Corporation
11.12.1 Sysmex Corporation Company Details
11.12.2 Sysmex Corporation Business Overview
11.12.3 Sysmex Corporation Circulating Tumor Cell Diagnostics Introduction
11.12.4 Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.12.5 Sysmex Corporation Recent Developments
11.13 Greiner Bio-One GmbH
11.13.1 Greiner Bio-One GmbH Company Details
11.13.2 Greiner Bio-One GmbH Business Overview
11.13.3 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Introduction
11.13.4 Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.13.5 Greiner Bio-One GmbH Recent Developments
11.14 AdnaGen AG
11.14.1 AdnaGen AG Company Details
11.14.2 AdnaGen AG Business Overview
11.14.3 AdnaGen AG Circulating Tumor Cell Diagnostics Introduction
11.14.4 AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.14.5 AdnaGen AG Recent Developments
11.15 Apocell Inc
11.15.1 Apocell Inc Company Details
11.15.2 Apocell Inc Business Overview
11.15.3 Apocell Inc Circulating Tumor Cell Diagnostics Introduction
11.15.4 Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.15.5 Apocell Inc Recent Developments
11.16 Biocep Ltd
11.16.1 Biocep Ltd Company Details
11.16.2 Biocep Ltd Business Overview
11.16.3 Biocep Ltd Circulating Tumor Cell Diagnostics Introduction
11.16.4 Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.16.5 Biocep Ltd Recent Developments
11.17 Canopus Bioscience Ltd
11.17.1 Canopus Bioscience Ltd Company Details
11.17.2 Canopus Bioscience Ltd Business Overview
11.17.3 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Introduction
11.17.4 Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.17.5 Canopus Bioscience Ltd Recent Developments
11.18 Creatv Microtech Inc
11.18.1 Creatv Microtech Inc Company Details
11.18.2 Creatv Microtech Inc Business Overview
11.18.3 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Introduction
11.18.4 Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.18.5 Creatv Microtech Inc Recent Developments
11.19 Ikonisys Inc
11.19.1 Ikonisys Inc Company Details
11.19.2 Ikonisys Inc Business Overview
11.19.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Introduction
11.19.4 Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.19.5 Ikonisys Inc Recent Developments
11.20 IV Diagnostics Inc
11.20.1 IV Diagnostics Inc Company Details
11.20.2 IV Diagnostics Inc Business Overview
11.20.3 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Introduction
11.20.4 IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.20.5 IV Diagnostics Inc Recent Developments
11.21 Miltenyi Biotech GmbH
11.21.1 Miltenyi Biotech GmbH Company Details
11.21.2 Miltenyi Biotech GmbH Business Overview
11.21.3 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Introduction
11.21.4 Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.21.5 Miltenyi Biotech GmbH Recent Developments
11.22 Nanostring Technologies Inc
11.22.1 Nanostring Technologies Inc Company Details
11.22.2 Nanostring Technologies Inc Business Overview
11.22.3 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Introduction
11.22.4 Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.22.5 Nanostring Technologies Inc Recent Developments
11.23 Rarecells Diagnostics.
11.23.1 Rarecells Diagnostics. Company Details
11.23.2 Rarecells Diagnostics. Business Overview
11.23.3 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Introduction
11.23.4 Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.23.5 Rarecells Diagnostics. Recent Developments
11.24 Vitatex Inc
11.24.1 Vitatex Inc Company Details
11.24.2 Vitatex Inc Business Overview
11.24.3 Vitatex Inc Circulating Tumor Cell Diagnostics Introduction
11.24.4 Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022)
11.24.5 Vitatex Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cell Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Circulating Tumor Cell Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Circulating Tumor Cell Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Circulating Tumor Cell Diagnostics Market Share by Region (2017-2022)
Table 9. Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Circulating Tumor Cell Diagnostics Market Share by Region (2023-2028)
Table 11. Circulating Tumor Cell Diagnostics Market Trends
Table 12. Circulating Tumor Cell Diagnostics Market Drivers
Table 13. Circulating Tumor Cell Diagnostics Market Challenges
Table 14. Circulating Tumor Cell Diagnostics Market Restraints
Table 15. Global Circulating Tumor Cell Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Circulating Tumor Cell Diagnostics Revenue Share by Players (2017-2022)
Table 17. Global Top Circulating Tumor Cell Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell Diagnostics as of 2021)
Table 18. Ranking of Global Top Circulating Tumor Cell Diagnostics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cell Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Circulating Tumor Cell Diagnostics Product Solution and Service
Table 22. Date of Enter into Circulating Tumor Cell Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type (2017-2022)
Table 26. Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type (2023-2028)
Table 28. Global Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Circulating Tumor Cell Diagnostics Revenue Share by Application (2017-2022)
Table 30. Global Circulating Tumor Cell Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Circulating Tumor Cell Diagnostics Revenue Share by Application (2023-2028)
Table 32. North America Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Circulating Tumor Cell Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Circulating Tumor Cell Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Janssen Diagnostics Company Details
Table 63. Janssen Diagnostics Business Overview
Table 64. Janssen Diagnostics Circulating Tumor Cell Diagnostics Product
Table 65. Janssen Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 66. Janssen Diagnostics Recent Developments
Table 67. Advanced Cell Diagnostics Company Details
Table 68. Advanced Cell Diagnostics Business Overview
Table 69. Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Product
Table 70. Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 71. Advanced Cell Diagnostics Recent Developments
Table 72. Aviva Biosciences Company Details
Table 73. Aviva Biosciences Business Overview
Table 74. Aviva Biosciences Circulating Tumor Cell Diagnostics Product
Table 75. Aviva Biosciences Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 76. Aviva Biosciences Recent Developments
Table 77. Biocept Inc Company Details
Table 78. Biocept Inc Business Overview
Table 79. Biocept Inc Circulating Tumor Cell Diagnostics Product
Table 80. Biocept Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 81. Biocept Inc Recent Developments
Table 82. Biofluidica Inc. Company Details
Table 83. Biofluidica Inc. Business Overview
Table 84. Biofluidica Inc. Circulating Tumor Cell Diagnostics Product
Table 85. Biofluidica Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 86. Biofluidica Inc. Recent Developments
Table 87. CellTraffix Inc. Company Details
Table 88. CellTraffix Inc. Business Overview
Table 89. CellTraffix Inc. Circulating Tumor Cell Diagnostics Product
Table 90. CellTraffix Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 91. CellTraffix Inc. Recent Developments
Table 92. Clearbridge BioMedics Pte Ltd Company Details
Table 93. Clearbridge BioMedics Pte Ltd Business Overview
Table 94. Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Product
Table 95. Clearbridge BioMedics Pte Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 96. Clearbridge BioMedics Pte Ltd Recent Developments
Table 97. Epic Sciences Inc. Company Details
Table 98. Epic Sciences Inc. Business Overview
Table 99. Epic Sciences Inc. Circulating Tumor Cell Diagnostics Product
Table 100. Epic Sciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 101. Epic Sciences Inc. Recent Developments
Table 102. Fluxion Biosciences Inc. Company Details
Table 103. Fluxion Biosciences Inc. Business Overview
Table 104. Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Product
Table 105. Fluxion Biosciences Inc. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 106. Fluxion Biosciences Inc. Recent Developments
Table 107. ScreenCell Company Details
Table 108. ScreenCell Business Overview
Table 109. ScreenCell Circulating Tumor Cell Diagnostics Product
Table 110. ScreenCell Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 111. ScreenCell Recent Developments
Table 112. Silicon Biosystems Company Details
Table 113. Silicon Biosystems Business Overview
Table 114. Silicon Biosystems Circulating Tumor Cell Diagnostics Product
Table 115. Silicon Biosystems Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 116. Silicon Biosystems Recent Developments
Table 117. Sysmex Corporation Company Details
Table 118. Sysmex Corporation Business Overview
Table 119. Sysmex Corporation Circulating Tumor Cell Diagnostics Product
Table 120. Sysmex Corporation Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 121. Sysmex Corporation Recent Developments
Table 122. Greiner Bio-One GmbH Company Details
Table 123. Greiner Bio-One GmbH Business Overview
Table 124. Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Product
Table 125. Greiner Bio-One GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 126. Greiner Bio-One GmbH Recent Developments
Table 127. AdnaGen AG Company Details
Table 128. AdnaGen AG Business Overview
Table 129. AdnaGen AG Circulating Tumor Cell Diagnostics Product
Table 130. AdnaGen AG Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 131. AdnaGen AG Recent Developments
Table 132. Apocell Inc Company Details
Table 133. Apocell Inc Business Overview
Table 134. Apocell Inc Circulating Tumor Cell Diagnostics Product
Table 135. Apocell Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 136. Apocell Inc Recent Developments
Table 137. Biocep Ltd Company Details
Table 138. Biocep Ltd Business Overview
Table 139. Biocep Ltd Circulating Tumor Cell Diagnostics Product
Table 140. Biocep Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 141. Biocep Ltd Recent Developments
Table 142. Canopus Bioscience Ltd Company Details
Table 143. Canopus Bioscience Ltd Business Overview
Table 144. Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Product
Table 145. Canopus Bioscience Ltd Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 146. Canopus Bioscience Ltd Recent Developments
Table 147. Creatv Microtech Inc Company Details
Table 148. Creatv Microtech Inc Business Overview
Table 149. Creatv Microtech Inc Circulating Tumor Cell Diagnostics Product
Table 150. Creatv Microtech Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 151. Creatv Microtech Inc Recent Developments
Table 152. Ikonisys Inc Company Details
Table 153. Ikonisys Inc Business Overview
Table 154. Ikonisys Inc Circulating Tumor Cell Diagnostics Product
Table 155. Ikonisys Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 156. Ikonisys Inc Recent Developments
Table 157. IV Diagnostics Inc Company Details
Table 158. IV Diagnostics Inc Business Overview
Table 159. IV Diagnostics Inc Circulating Tumor Cell Diagnostics Product
Table 160. IV Diagnostics Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 161. IV Diagnostics Inc Recent Developments
Table 162. Miltenyi Biotech GmbH Company Details
Table 163. Miltenyi Biotech GmbH Business Overview
Table 164. Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Product
Table 165. Miltenyi Biotech GmbH Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 166. Miltenyi Biotech GmbH Recent Developments
Table 167. Nanostring Technologies Inc Company Details
Table 168. Nanostring Technologies Inc Business Overview
Table 169. Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Product
Table 170. Nanostring Technologies Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 171. Nanostring Technologies Inc Recent Developments
Table 172. Rarecells Diagnostics. Company Details
Table 173. Rarecells Diagnostics. Business Overview
Table 174. Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Product
Table 175. Rarecells Diagnostics. Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 176. Rarecells Diagnostics. Recent Developments
Table 177. Vitatex Inc Company Details
Table 178. Vitatex Inc Business Overview
Table 179. Vitatex Inc Circulating Tumor Cell Diagnostics Product
Table 180. Vitatex Inc Revenue in Circulating Tumor Cell Diagnostics Business (2017-2022) & (US$ Million)
Table 181. Vitatex Inc Recent Developments
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cell Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. CTC Enrichment Features
Figure 3. CTC Detection Features
Figure 4. CTC Analysis Features
Figure 5. Global Circulating Tumor Cell Diagnostics Market Share by Application: 2021 VS 2028
Figure 6. Tumorigenesis research Case Studies
Figure 7. EMT biomarkers development Case Studies
Figure 8. Cancer stem cell research Case Studies
Figure 9. Others Case Studies
Figure 10. Circulating Tumor Cell Diagnostics Report Years Considered
Figure 11. Global Circulating Tumor Cell Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Circulating Tumor Cell Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Circulating Tumor Cell Diagnostics Market Share by Region: 2021 VS 2028
Figure 14. Global Circulating Tumor Cell Diagnostics Market Share by Players in 2021
Figure 15. Global Top Circulating Tumor Cell Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell Diagnostics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Circulating Tumor Cell Diagnostics Revenue in 2021
Figure 17. North America Circulating Tumor Cell Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Circulating Tumor Cell Diagnostics Market Size Market Share by Type (2017-2028)
Figure 19. North America Circulating Tumor Cell Diagnostics Market Size Market Share by Application (2017-2028)
Figure 20. North America Circulating Tumor Cell Diagnostics Market Size Share by Country (2017-2028)
Figure 21. United States Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Circulating Tumor Cell Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Circulating Tumor Cell Diagnostics Market Size Market Share by Type (2017-2028)
Figure 25. Europe Circulating Tumor Cell Diagnostics Market Size Market Share by Application (2017-2028)
Figure 26. Europe Circulating Tumor Cell Diagnostics Market Size Share by Country (2017-2028)
Figure 27. Germany Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cell Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Circulating Tumor Cell Diagnostics Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Circulating Tumor Cell Diagnostics Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Circulating Tumor Cell Diagnostics Market Size Share by Region (2017-2028)
Figure 37. China Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Circulating Tumor Cell Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Circulating Tumor Cell Diagnostics Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Circulating Tumor Cell Diagnostics Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Circulating Tumor Cell Diagnostics Market Size Share by Country (2017-2028)
Figure 47. Mexico Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Circulating Tumor Cell Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Circulating Tumor Cell Diagnostics Market Size Share by Country (2017-2028)
Figure 53. Turkey Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Circulating Tumor Cell Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Janssen Diagnostics Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 57. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 58. Aviva Biosciences Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 59. Biocept Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 60. Biofluidica Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 61. CellTraffix Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 62. Clearbridge BioMedics Pte Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 63. Epic Sciences Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 64. Fluxion Biosciences Inc. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 65. ScreenCell Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 66. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 67. Sysmex Corporation Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 68. Greiner Bio-One GmbH Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 69. AdnaGen AG Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 70. Apocell Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 71. Biocep Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 72. Canopus Bioscience Ltd Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 73. Creatv Microtech Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 74. Ikonisys Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 75. IV Diagnostics Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 76. Miltenyi Biotech GmbH Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 77. Nanostring Technologies Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 78. Rarecells Diagnostics. Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 79. Vitatex Inc Revenue Growth Rate in Circulating Tumor Cell Diagnostics Business (2017-2022)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Janssen Diagnostics Advanced Cell Diagnostics Aviva Biosciences Biocept Inc Biofluidica Inc. CellTraffix Inc. Clearbridge BioMedics Pte Ltd Epic Sciences Inc. Fluxion Biosciences Inc. ScreenCell Silicon Biosystems Sysmex Corporation Greiner Bio-One GmbH AdnaGen AG Apocell Inc Biocep Ltd Canopus Bioscience Ltd Creatv Microtech Inc Ikonisys Inc IV Diagnostics Inc Miltenyi Biotech GmbH Nanostring Technologies Inc Rarecells Diagnostics. Vitatex Inc